Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (484 ops.)
Latest filing published 17 Mar 2026 for UNITED THERAPEUTICS Corp.
Filing timeline
BuySaleMichael Benkowitz
First 200 filings with a declared amount
Insider track record
Disclosed buys
0
Disclosed sells
484
Signal history
Michael Benkowitz: trading record in brief
Michael Benkowitz has filed 664 times for UNITED THERAPEUTICS Corp, where Benkowitz is President and Chief Operating Officer, between November 3, 2020 and March 17, 2026. The record holds 481 sales, worth EUR 304,511,842 in total with a median of EUR 255,839, and no purchase. The three largest are EUR 6,246,007 (December 29, 2025), EUR 6,033,156 (January 12, 2026) and EUR 6,012,943 (December 8, 2025), three close amounts, all around EUR 6 million.
The 143 option exercises, 38 other filings and 2 grants complete the series.
The concentration in time is strong: 337 filings in 2025 and 163 in 2024, against 4 in 2020, 60 in 2021 and 2 in 2023. Over the last twelve months, 183 filings are recorded, 139 of them sales.
Overlaps with colleagues are massive: 357 of Benkowitz's market trades fall within 30 days of a trade by Paul A. Mahon, 273 by Christopher Causey, 257 by Nilda Mesa, 248 by Tommy G. Thompson and 239 by Christopher Patusky, all in the same direction. Filings are published a median of 1 day after the trade.
Companies and markets linked to Michael Benkowitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations664 total
15,592 sharesCommon StockSEC:0001673232-26-000013:1
7,837 shares@ US$536.120.8% of flowCommon StockSEC:0001673232-26-000013:2
6,869 shares@ US$536.120.7% of flowCommon StockSEC:0001673232-26-000013:3
17,790 sharesCommon StockSEC:0001673232-26-000013:0
9,375 shares@ US$472.130.8% of flowCommon StockSEC:0001673232-26-000011:1
5,065 shares@ US$146.030.1% of flowCommon StockSEC:0001673232-26-000011:2
5,065 shares@ US$472.130.4% of flowCommon StockSEC:0001673232-26-000011:3
9,375 shares@ US$117.760.6% of flowCommon StockSEC:0001673232-26-000011:0
14,625 shares@ US$480.751.3% of flowCommon StockSEC:0001673232-26-000010:1
7,875 shares@ US$146.030.2% of flowCommon StockSEC:0001673232-26-000010:2
7,875 shares@ US$480.750.7% of flowCommon StockSEC:0001673232-26-000010:3
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000010:0
14,625 shares@ US$474.651.3% of flowCommon StockSEC:0001673232-26-000009:1
7,875 shares@ US$146.030.2% of flowCommon StockSEC:0001673232-26-000009:2
7,875 shares@ US$474.650.7% of flowCommon StockSEC:0001673232-26-000009:3
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000009:0
14,625 shares@ US$470.951.2% of flowCommon StockSEC:0001673232-26-000008:1
7,875 shares@ US$146.030.2% of flowCommon StockSEC:0001673232-26-000008:2
7,875 shares@ US$470.950.7% of flowCommon StockSEC:0001673232-26-000008:3
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000008:0
498 shares@ US$459.870.0% of flowCommon StockSEC:0001673232-26-000006:4
503 shares@ US$461.120.0% of flowCommon StockSEC:0001673232-26-000006:5
63 shares@ US$456.870.0% of flowCommon StockSEC:0001673232-26-000007:1
372 shares@ US$457.920.0% of flowCommon StockSEC:0001673232-26-000007:2
377 shares@ US$458.740.0% of flowCommon StockSEC:0001673232-26-000007:3
25 of 664 declarations
